Frequently Asked Questions
The major companies in the genetic testing market are Thermo Fisher Scientific Inc. (U.S.), Invitae Corporation (U.S.), Bio-Rad Laboratories, Inc. (U.S.), PerkinElmer Inc. (U.S.), Illumina, Inc. (U.S.), QIAGEN (Germany), F. Hoffmann-La Roche Ltd. (Switzerland), Fulgent Genetics (U.S.), Myriad Genetics, Inc. (U.S.), Abbott (U.S.), Eurofins Scientific (Luxembourg), Sorenson Genomics (U.S.), BIO-HELIX (U.S.), Biocartis (Belgium), Cepheid (U.S.), PacBio (U.S.), ELITechGroup (France), Genes2Me (India), Eugene Labs (U.S.), Otogenetics (U.S.), Mapmygenome (India), MedGenome (India), BioReference Health, LLC (U.S.), Natera, Inc. (U.S.).
The type, technology, diseases, and end-user are the factors on which the genetic testing market research is based.
High Demand of Genetic Testing due to Increasing Importance of Cancer Genetic Testing and Rapid Technological Advancements Enhances Genetic Testing are the growth drivers of the genetic testing market.
The genetic testing market size will be worth USD 6,26,07,580.19 thousand by 2031.
The genetic testing market growth rate will be 16.5% by 2031.
